BlackRock Fund Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $14.8M | Buy |
3,894,087
+445,087
| +13% | +$1.69M | ﹤0.01% | 2351 |
|
|
2016
Q3 | $30.9M | Buy |
3,449,000
+345,672
| +11% | +$3.1M | 0.01% | 1859 |
|
|
2016
Q2 | $21.8M | Buy |
3,103,328
+255,785
| +9% | +$1.8M | ﹤0.01% | 1976 |
|
|
2016
Q1 | $24.2M | Buy |
2,847,543
+318,167
| +13% | +$2.7M | 0.01% | 1874 |
|
|
2015
Q4 | $33.2M | Sell |
2,529,376
-141,489
| -5% | -$1.86M | 0.01% | 1750 |
|
|
2015
Q3 | $9.78M | Buy |
2,670,865
+101,091
| +4% | +$370K | ﹤0.01% | 2381 |
|
|
2015
Q2 | $14.8M | Sell |
2,569,774
-3,875
| -0.2% | -$22.3K | ﹤0.01% | 2290 |
|
|
2015
Q1 | $15M | Buy |
2,573,649
+122,799
| +5% | +$717K | ﹤0.01% | 2218 |
|
|
2014
Q4 | $19.2M | Buy |
2,450,850
+200,158
| +9% | +$1.57M | ﹤0.01% | 2090 |
|
|
2014
Q3 | $11.1M | Buy |
2,250,692
+3,255
| +0.1% | +$16K | ﹤0.01% | 2290 |
|
|
2014
Q2 | $13.9M | Buy |
2,247,437
+61,809
| +3% | +$382K | ﹤0.01% | 2222 |
|
|
2014
Q1 | $11.7M | Buy |
2,185,628
+110,428
| +5% | +$591K | ﹤0.01% | 2307 |
|
|
2013
Q4 | $10.9M | Buy |
2,075,200
+12,196
| +0.6% | +$63.8K | ﹤0.01% | 2347 |
|
|
2013
Q3 | $11.4M | Buy |
2,063,004
+370,015
| +22% | +$2.04M | ﹤0.01% | 2280 |
|
|
2013
Q2 | $4.28M | Buy |
+1,692,989
| New | +$4.28M | ﹤0.01% | 2789 |
|